A Tip of the Cap for a Truly Innovative Cardiologist
Grüntzig's first successful coronary angioplasty treatment on an awake human was performed in 1977. The immediate results of this treatment, despite using only a carefully kitchen built catheter were quite good. The LAD artery narrowing remained almost perfectly expanded.
Dr. Grüntzig recognized multiple important issues early:
Understanding these issues and tireless effort on his part are widely recognized in cardiology for leading to the ultimate success of the technique.
Meet The Conductor Guidewire – Our Flagship Product
The Conductor Coronary Guidewire:
Where other devices fail, the Conductor will get you through! Our products are precision engineered and have been developed specifically for tight lesions, complex navigation, and difficult approaches.
The Conductor Coronary Guidewires are designed to provide:
What Does the Future Hold – What is in the Product Pipeline?
Transcatheter aortic valve implantation (TAVI) is a new, minimally invasive approach to replacing diseased aortic valves. In TAVI, an artificial aortic valve is implanted by means of a sophisticated catheterization procedure.
Currently, our collaboration with Dr. Mark Webster from New Zealand has produced a very specific product in this area of Interventional Cardiology. The product is called the “S-Wire” which has a specific application for artificial aortic valve replacement.
How Do I Implement One of My Innovative Product Ideas Like Dr. Webster?
We believe that all of our great relationships start with a conversation. Start one now!